TLP
Tri Locum Partners Portfolio holdings
AUM
$330M
This Quarter Return
+11.86%
1 Year Return
+35.44%
3 Year Return
+388.28%
5 Year Return
–
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(+37%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
26.97%
Top 10 Holdings %
Top 10 Hldgs %
65.16%
Holding
37
New
10
Increased
12
Reduced
2
Closed
12
Top Buys
| 1 |
Amgen
AMGN
|
$25.7M |
| 2 |
Insmed
INSM
|
$21.2M |
| 3 |
argenx
ARGX
|
$20M |
| 4 |
Pfizer
PFE
|
$16.7M |
| 5 |
Axsome Therapeutics
AXSM
|
$16.4M |
Top Sells
| 1 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$19.9M |
| 2 |
Merck
MRK
|
$15.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$14.9M |
| 4 |
Baxter International
BAX
|
$13.6M |
| 5 |
Tandem Diabetes Care
TNDM
|
$11.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $41.4M | 10.48% | 2,550,307 +334,119 | +15% | +$5.43M |
|
|
2
argenx
ARGX
$43.6B
| $32.1M | 8.11% | 74,558 +46,577 | +166% | +$20M |
|
3
Ascendis Pharma
ASND
$11.8B
| $31.1M | 7.85% | 227,762 +115,092 | +102% | +$15.7M |
|
|
4
Amgen
AMGN
$155B
| $25.7M | 6.5% | +82,271 | New | +$25.7M |
|
5
Natera
NTRA
$23.1B
| $25M | 6.31% | 230,585 +40,471 | +21% | +$4.38M |
|
|
6
Axsome Therapeutics
AXSM
$6.05B
| $24.7M | 6.24% | 306,513 +203,802 | +198% | +$16.4M |
|
|
7
Insmed
INSM
$28.8B
| $21.2M | 5.36% | +316,501 | New | +$21.2M |
|
8
Merus
MRUS
$4.98B
| $19.9M | 5.02% | 335,514 +49,192 | +17% | +$2.91M |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $18.4M | 4.65% | 17,516 +8,949 | +104% | +$9.41M |
|
10
Madrigal Pharmaceuticals
MDGL
$9.76B
| $18.3M | 4.63% | 65,352 +11,997 | +22% | +$3.36M |
|
11
Inspire Medical Systems
INSP
$2.77B
| $17.8M | 4.51% | 133,276 +109,710 | +466% | +$14.7M |
|
|
AVDL
12
Avadel Pharmaceuticals
AVDL
$1.43B
| $16.7M | 4.23% | 1,189,518 +7 | +0% | +$98 |
|
|
13
Pfizer
PFE
$141B
| $16.7M | 4.22% | +596,919 | New | +$16.7M |
|
14
United Therapeutics
UTHR
$13.8B
| $16M | 4.04% | +50,100 | New | +$16M |
|
15
Legend Biotech
LEGN
$6.41B
| $15.8M | 3.99% | 356,532 +72,759 | +26% | +$3.22M |
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $10.9M | 2.76% | +45,000 | New | +$10.9M |
|
17
Stevanato
STVN
$6.28B
| $10.4M | 2.62% | +565,422 | New | +$10.4M |
|
18
Novo Nordisk
NVO
$251B
| $9.11M | 2.3% | +63,811 | New | +$9.11M |
|
19
Vaxcyte
PCVX
$4B
| $8.56M | 2.16% | +113,344 | New | +$8.56M |
|
20
Xenon Pharmaceuticals
XENE
$2.98B
| $3.98M | 1.01% | 101,959 -105,506 | -51% | -$4.11M |
|
21
Ocular Therapeutix
OCUL
$2.12B
| $3.52M | 0.89% | +514,642 | New | +$3.52M |
|
22
Praxis Precision Medicines
PRAX
$958M
| $3.12M | 0.79% | 75,319 -31,175 | -29% | -$1.29M |
|
23
MindMed
MNMD
$676M
| $2.75M | 0.7% | 382,055 +2,459 | +0.6% | +$17.7K |
|
24
Korro Bio
KRRO
$217M
| $2.42M | 0.61% | +71,428 | New | +$2.42M |
|
25
Femasys
FEMY
$11.6M
| $34.9K | 0.01% | 30,606 | – | – |
|